Douglas Clark stepping down as Executive Director of the PMPRB 

Douglas Clark, Executive Director of the Patented Medicine Prices Review Board (PMPRB), has announced that he will be stepping down from that position after almost a decade at the PMPRB.

February 24, 2023 — Ottawa, ON — Patented Medicine Prices Review Board

Douglas Clark, Executive Director of the Patented Medicine Prices Review Board (PMPRB), has announced that he will be stepping down from that position after almost a decade at the PMPRB. Before joining the PMPRB, Mr. Clark served as Assistant Deputy Commissioner with the Competition Bureau and before that as Director of the Patent Policy Directorate at Innovation, Science and Economic Development. Mr. Clark has agreed to remain with the PMPRB as a special advisor to the Board for a specified period as he transitions to retirement from the federal public service. A staffing process to appoint Mr. Clark’s successor will be launched shortly.

The PMPRB wishes to thank Mr. Clark for his years of dedicated service and leadership.

"In his nine years at the Board, Doug has been an outstanding leader, creating and sustaining a high-performance leadership team and developing an internal culture which is widely admired across the government. At the behest of the Board, he succeeded in testing the limits of the PMPRB's mandate, in the boldest tradition of the federal public service, opening the path for future Boards to implement predictable processes with confidence and clarity. The results he delivered on preventing excessive pricing of pharmaceuticals in Canada are having a deep and lasting impact on the sustainability of the entire Canadian health care system. On behalf of the Board, I offer our thanks for his years of dedication and commitment, and heartfelt wish that he, and his family, find success wherever their future path may take them."